Back to Journals » Biologics: Targets and Therapy » Volume 13

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Total article views   Abstract views HTML views PDF downloads Totals
3,427 Dovepress* 2,922 230+ 675 3,152
PubMed Central* 0 275 109 275
Totals 2,922 505 784 3,427
*Since 3 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar